Physician profile

Heidi Lee

Pain Medicine (Anesthesiology) · Addison, TX

NPI 1437577384

$4,547.27

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$65.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Relievant Medsystems, INC. $1,317.75 2020-2022
Medtronic USA, INC. $1,178.69 2019
Nevro Corp. $1,170.22 2019-2021
Boston Scientific Corporation $294.30 2019
Abbott Laboratories $242.83 2019-2022
Spr Therapeutics, INC $236.58 2019-2023 Sprint Pns System
Flowonix Medical Incorporated $76.71 2019
Medtronic, INC. $16.82 2021
Arbor Pharmaceuticals, INC. $13.37 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Heidi Lee

$4,547.27

in general payments reported 2019-2025

Years
2019-2023
Top company
Relievant Medsystems, INC.

https://glasscript.com/doctor/5700608/heidi-lee

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.